Dataset Information

Vav3 modulates B cell receptor responses by regulating phosphoinositide 3-kinase activation.

ABSTRACT: To elucidate the mechanism(s) by which Vav3, a new member of the Vav family proteins, participates in B cell antigen receptor (BCR) signaling, we have generated a B cell line deficient in Vav3. Here we report that Vav3 influences phosphoinositide 3-kinase (PI3K) function through Rac1 in that phosphatidylinositol-3,4,5-trisphosphate (PIP3) generation was attenuated by loss of Vav3 or by expression of a dominant negative form of Rac1. The functional interaction between PI3K and Rac1 was also demonstrated by increased PI3K activity in the presence of GTP-bound Rac1. In addition, we show that defects of calcium mobilization and c-Jun NH2-terminal kinase (JNK) activation in Vav3-deficient cells are relieved by deletion of a PIP3 hydrolyzing enzyme, SH2 domain-containing inositol polyphosphate 5'-phosphatase (SHIP). Hence, our results suggest a role for Vav3 in regulating the B cell responses by promoting the sustained production of PIP3 and thereby calcium flux.

SUBMITTER: Inabe K

PROVIDER: S-EPMC2193613 | biostudies-literature | 2002 Jan

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Vav3 modulates B cell receptor responses by regulating phosphoinositide 3-kinase activation.

Inabe Kazunori K Ishiai Masamichi M Scharenberg Andrew M AM Freshney Norman N Downward Julian J Kurosaki Tomohiro T

The Journal of experimental medicine 20020101 2

To elucidate the mechanism(s) by which Vav3, a new member of the Vav family proteins, participates in B cell antigen receptor (BCR) signaling, we have generated a B cell line deficient in Vav3. Here we report that Vav3 influences phosphoinositide 3-kinase (PI3K) function through Rac1 in that phosphatidylinositol-3,4,5-trisphosphate (PIP3) generation was attenuated by loss of Vav3 or by expression of a dominant negative form of Rac1. The functional interaction between PI3K and Rac1 was also demon ...[more]

PMID: 11805146

Similar Datasets

Project description:Transforming growth factor ? (TGF?) induces hepatic stellate cell (HSC) differentiation into tumor-promoting myofibroblast, although underlying mechanism remains incompletely understood. Focal adhesion kinase (FAK) is activated in response to TGF? stimulation, so it transmits TGF? stimulus to extracellular signal-regulated kinase and P38 mitogen-activated protein kinase signaling. However, it is unknown whether FAK can, in return, modulate TGF? receptors. In this study, we tested whether FAK phosphorylated TGF? receptor 2 (TGF?R2) and regulated TGF?R2 intracellular trafficking in HSCs. The FAKY397F mutant and PF-573,228 were used to inhibit the kinase activity of FAK, the TGF?R2 protein level was quantitated by immunoblotting, and HSC differentiation into myofibroblast was assessed by expression of HSC activation markers, alpha-smooth muscle actin, fibronectin, or connective tissue growth factor. We found that targeting FAK kinase activity suppressed the TGF?R2 protein level, TGF?1-induced mothers against decapentaplegic homolog phosphorylation, and myofibroblastic activation of HSCs. At the molecular and cellular level, active FAK (phosphorylated FAK at tyrosine 397) bound to TGF?R2 and kept TGF?R2 at the peripheral plasma membrane of HSCs, and it induced TGF?R2 phosphorylation at tyrosine 336. In contrast, targeting FAK or mutating Y336 to F on TGF?R2 led to lysosomal sorting and degradation of TGF?R2. Using RNA sequencing, we identified that the transcripts of 764 TGF? target genes were influenced by FAK inhibition, and that through FAK, TGF?1 stimulated HSCs to produce a panel of tumor-promoting factors, including extracellular matrix remodeling proteins, growth factors and cytokines, and immune checkpoint molecule PD-L1. Functionally, targeting FAK inhibited tumor-promoting effects of HSCs in vitro and in a tumor implantation mouse model. Conclusion: FAK targets TGF?R2 to the plasma membrane and protects TGF?R2 from lysosome-mediated degradation, thereby promoting TGF?-mediated HSC activation. FAK is a target for suppressing HSC activation and the hepatic tumor microenvironment.

Dataset Information

Vav3 modulates B cell receptor responses by regulating phosphoinositide 3-kinase activation.

Publications

Vav3 modulates B cell receptor responses by regulating phosphoinositide 3-kinase activation.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure